𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Azacytidine for the treatment of myelodysplastic syndromes in the elderly

✍ Scribed by Maria Diez Campelo; Regina Garcia Delgado; Ana Cristina Godoy Molias; Jesus Feliu Sanchez

Publisher
Springer Healthcare Communications
Year
2011
Tongue
English
Weight
464 KB
Volume
28
Category
Article
ISSN
0741-238X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The treatment of the myelodysplastic syn
The treatment of the myelodysplastic syndromes
✍ Harvey D. Preisler πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

T he article by Ferrara et al. 1 in this issue of Cancer describes the treatment of patients with poor prognosis myelodysplastic syndromes (MDS) using intensive remission induction chemotherapy followed by peripheral blood stem cell transplantation for patients age Ο½ 60 years. Thirty-two patients wi

Combination of 5-azacytidine and thalido
Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia
✍ Azra Raza; Murtaza Mehdi; Muhammad Mumtaz; Fahad Ali; Steven Lascher; Naomi Gali πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 224 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The treatment of myelodysplastic syndromes (MDS) remains a challenge to the clinician despite recent advances. Many patients will either not respond or will have only limited and/or brief responses to single‐agent therapy. Eventually, 30% of patients with MDS will progre